Genetic ablation of HOIP results in embryonic lethality at midgestation (E10.5) Conditional HOIP deletion in the endothelium is sufficient to cause embryonic death Defective yolk sac vascularization is causative for embryonic lethality at E10. 
In Brief
HOIP is the main catalytic subunit of the linear ubiquitin chain assembly complex (LUBAC), a crucial regulator of TNF and other immune signaling pathways. Peltzer et al. find that HOIP deficiency results in embryonic lethality at midgestation due to endothelial cell death mediated by TNFR1. Aberrant formation of a TNFmediated cell-death-inducing complex in HOIP-deficient (but not -proficient) cells underlies the phenotype, with the catalytic activity of HOIP required for the control of cell death in response to TNF.
INTRODUCTION
Ubiquitination is the covalent attachment of ubiquitin to a target protein. When ubiquitin itself is the target, interubiquitin linkages are formed. Eight amino groups within the ubiquitin moiety, namely the respective ε-amino groups on its seven lysines and the a-amino group on the amino-terminal methionine (M1), can serve as acceptor for the terminal carboxyl group of the incoming ubiquitin. Thereby, eight structurally and functionally distinct diubiquitin linkage types can be generated (Komander, 2009) . The ubiquitin linkage resulting from the use of M1 of ubiquitin, the so-called linear ubiquitin linkage, is involved in gene activation and regulates inflammation and cell death in several innate and adaptive immune signaling pathways (Iwai et al., 2014; Rieser et al., 2013; Walczak et al., 2012) . The linear ubiquitin chain assembly complex (LUBAC) is currently the only known E3 ligase that generates linear linkages under physiological conditions and is composed of three proteins-heme-oxidized iron-responsive element-binding protein 2 (IRP2) ubiquitin ligase-1 (HOIL-1; also known as RanBP-type and C3HC4-type zinc finger-containing protein 1 [RBCK1]), HOIL-1 interacting protein (HOIP; also known as ring finger protein 31 [RNF31]), and SH3 and multiple ankyrin repeat domains protein (SHANK)-associated RBCK1 homology (RH)-domain-interacting protein (SHARPIN; also known as SHANK-interacting protein-like 1 [SIPL1]) (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) -with HOIP being the catalytically active component of this complex (Tokunaga et al., 2009) .
LUBAC has been identified to regulate various signaling pathways that promote canonical NF-kB activation, including the ones triggered by tumor necrosis factor (TNF), nucleotide oligomerization domain 2 (NOD2), interleukin 1 (IL-1), and Toll-like receptor 2 (TLR2) and TLR4 (Damgaard et al., 2012; Emmerich et al., 2013; Gerlach et al., 2011; Sasaki et al., 2013; Zak et al., 2011; Zinngrebe et al., 2014) . The best-characterized pathway involving LUBAC is the one triggered by tumor necrosis factor receptor 1 (TNFR1) activation. The crucial hub in this pathway is the TNFR1-signaling complex (TNF-RSC). Upon binding to TNF, TNFR1 oligomerizes, resulting in recruitment of TRADD, TRAF2, cIAP1/2, and RIP1. cIAP1/2-mediated ubiquitination of components of the TNF-RSC leads to recruitment of the TAK1-TAB1-TAB2 complex for mitogen-activated protein kinase (MAPK) activation and of LUBAC. LUBAC in turn forms linear ubiquitin linkages on RIP1 and NEMO/IKKg, stabilizing and activating the IKKa-IKKb-NEMO/IKKg complex for optimal NF-kB activation (Gerlach et al., 2011; Schmukle and Walczak, 2012) . Alternatively, when the TNF-RSC is destabilized by inhibition, absence, or malfunction of its components, a secondary cytoplasmic complex, known as complex-II, is formed around RIP1 involving caspase-8, FADD, cFLIP, and RIP3. This complex induces cell death by apoptosis or necroptosis (Micheau and Tschopp, 2003; Tenev et al., 2011) .
The essential role of LUBAC in TNF signaling was evidenced in mice lacking SHARPIN (chronic proliferative dermatitis mice [cpdm] ), which develop a spontaneous inflammatory syndrome (Seymour et al., 2007) . We and others previously showed that cells derived from cpdm mice have decreased NF-kB activation and are more sensitive to TNF-induced cell death (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) . Importantly, we could further show that deletion of TNF in cpdm mice completely rescued them from the inflammatory disease (Gerlach et al., 2011) . Together, these results suggested TNF-dependent cell death as causative for the inflammatory manifestations of the cpdm phenotype. However, as linear ubiquitination is only suppressed, but not abolished, in the absence of SHARPIN, the effect of a complete lack in LUBAC activity on physiology is unknown. We therefore examined the physiological role of the catalytically active LUBAC component, HOIP, by studying mice deficient for this component. Here, we report that HOIP deletion leads to embryonic lethality at midgestation due to TNFR1-mediated aberrant death of endothelial cells, disrupting the vascular architecture.
RESULTS

HOIP Deficiency Results in Embryonic Lethality
HOIP-deficient C57BL/6 mice were obtained as described in Experimental Procedures (Figures S1A and S1B). Among more than 100 progeny from Hoip heterozygous mouse intercrosses, not a single mouse with homozygous deletion in the Hoip gene was born, indicating that HOIP deficiency results in embryonic lethality ( Figure 1A ). Western blotting of whole embryos confirmed HOIP absence and revealed a substantial concomitant decrease in HOIL-1 and SHARPIN expression ( Figure S1C ), in line with previous observations in vitro (Gerlach et al., 2011; Tokunaga et al., 2011) .
To define the embryonic stage at which HOIP-deficient (Hoip À/À ) embryos die, embryos were analyzed at different days of gestation. No morphological differences among Hoip +/+ , Hoip
, and Hoip À/À embryos were detected at 8 and 9 days of embryonic development (E8.5-E9.5) ( Figure S1D ; , and Hoip À/À embryos from E9.5 to E12.5. E9.5 Hoip À/À embryos appeared normal (i-iii), whereas E10.5 embryos lacked vascularization in the yolk sac and were smaller compared to wild-type littermates (iv-vi). At E11.5 and E12.5, embryos were dead (vii-ix and x-xii, respectively). Heterozygosity of Hoip has no detectable aberration. See also Figure S1D . (C) Vascular defects at E10.5 are shown macroscopically (i-iii) and microscopically by PECAM-1 staining in yolk sacs (iv-vi) . Histological analysis revealed heart defects such as enlargement of the pericardial cavity (black line) and thinning of the ventricular wall (arrow) (vii-ix). See also Figure S1E . (D) Branching point quantification of images in (C) (iv-vi). Statistics were performed by ANOVA for multiple comparisons. Data are presented as mean ± SEM (n = 3 yolk sacs).
(E) Quantification of the pericardial space was performed on five serial sections of the heart for each embryo. Data are presented as mean ± SEM (n = 3 embryos).
Figures 1B i-iii). At E10.5, however, Hoip À/À embryos were small and had aberrant vascularization with only few major vessels detected macroscopically . These embryos were resorbed at E11.5/12.5 (Figures 1B vii-ix and x-xii, respectively). Thus, Hoip À/À embryos die at E10.5.
Since absence of proper yolk sac vascularization could cause embryonic lethality, we examined the yolk sac endothelium in more detail. Staining of PECAM-1, an endothelial cell marker, revealed severe vascular architectural defects with decreased vascular density as determined by quantification of vessel branching points . Histological analysis showed abnormalities mainly in the embryos' hearts with enlargement of the pericardial space and marked attenuation of the ventricular wall ( Figures 1C vii-ix) , features associated with decreased vascular density in the yolk sac and, hence, less blood arriving at the heart. At E9.5, yolk sac vascularization was already affected, albeit mildly, whereas no aberrant phenotype was observed in the heart (Figures S1E and S1F). Thus, although defects start to appear at E9.5, the phenotype is manifest at E10.5, and nearly all embryos are dead by E11.5.
Importantly, Hoip is ubiquitously expressed at E10.5 as determined by in situ hybridization in wild-type embryos ( Figure S1G ), indicating that the vascular phenotype is a consequence of HOIP being required for normal vascularization at this developmental stage, rather than resulting from specific expression of HOIP in the vasculature.
Hoip
À/À Embryos Suffer from Excessive Endothelial Cell
Death at Midgestation
To study the cause of the disrupted vasculature in yolk sacs of Hoip À/À embryos, we analyzed cell death by whole-mount TUNEL staining. At E8.5, no difference was observed between , and by E10.5, this difference was dramatic, correlating with near-complete disruption of yolk sac vascular architecture and increased cell death in the heart of HOIP-deficient embryos (Figures S2C and S2D) . At E11.5, massive cell death in the yolk sac and in the embryo proper, particularly in heart and forebrain, was observed, correlating with resorption ( Figure S2E ).
Using cleaved caspase-3 as a marker of apoptotic cells, we found that apoptosis was increased in Hoip À/À yolk sacs at E9.5 ( Figure S2B ) and that this increase was even more pronounced at E10.5 ( Figures 2C and 2D ). At E11.5, cleaved caspase-3 was also detected in vessels throughout the embryo ( Figure S2F ) correlating with disruption of vascular architecture and death. As cleaved caspase-3 was present in PECAM-1 + cells ( Figure 2C ), apoptosis occurred in endothelial cells. These results suggest that in Hoip À/À embryos, excessive apoptosis of endothelial cells, most likely starting at E9.5 in the yolk sac and spreading over the next few days of embryonic development throughout the embryo (note that vascularization in the embryo proper is affected at E11.5, but not at E10.5; Figure S2F ), could be responsible for vascular defects and, consequently, lethality.
Endothelial Deletion of Hoip Phenocopies Constitutive Hoip Deletion
To evaluate whether HOIP deficiency in endothelial cells was indeed responsible for embryonic lethality at E10.5, we aimed to specifically delete HOIP from endothelial cells by crossing Figure S3C ).
As the Tie2 promoter is known to be activated early during embryogenesis (i.e., at E7.5) and thus before separation of the endothelial from the immune cell lineage (Haar and Ackerman, 1971; Hamaguchi et al., 2006) + cells by flow cytometry at E9.5 and E10.5 in whole embryos, including yolk sacs. At E9.5, we observed no effect of HOIP deficiency on immune cell viability ( Figure S3E ), while death of endothelial cells in the yolk sacs of these embryos was readily observed at this time ( Figure 3D ). At E10.5, however, there is a reduction in the percentage of the immune cell population. Therefore, although endothelial cell death appears to be the first, and hence probably triggering, event in yolk sacs of Hoip
embryos, immune cells are also affected. 
TNF Deletion Prevents Cell Death at Midgestation and Prolongs Survival of Hoip À/À Embryos
Given that LUBAC is essential for regulating TNF-induced cell death (Gerlach et al., 2011; Ikeda et al., 2011; Tokunaga et al., 2011) and that TNF ablation prevented inflammation in cpdm mice (Gerlach et Figures 4F and 4G ). This was further aggravated at E15.5 ( Figure 4F and G), when yolk sacs were completely devoid of major vessels, both macroand microscopically ( Figures 4A vii and 4F ). The fact that we could only detect vessels microscopically by PECAM-1 staining, and not macroscopically, is likely due to deprivation of blood supply as a consequence of endothelial cell death, which renders vessels undetectable macroscopically, whereas they remain detectable by staining for specific endothelial cell markers. Together, these results suggest that disruption of vascular architecture, even if delayed, is also causative for embryonic lethality at E15.5 in Tnf À/À Hoip À/À embryos.
TNFR1, but Not TNF, Deletion Markedly Reduces Cell Death and Restores Normal Vascularization
Apart from TNF, lymphotoxin-a (LT-a) also engages with and signals through TNFR1 (Aggarwal et al., 1985) . Indeed, we found that murine embryonic fibroblasts (MEFs) obtained from Tnf
Hoip À/À embryos to facilitate generation of MEFs deficient in HOIP) were rendered sensitive to death induction by both TNF and LT-a ( Figure 5A ), in line with the recently reported finding that SHARPIN-deficient cells are sensitized to TNF and LT-a (Etemadi et al., 2013) . On this basis we hypothesized that TNF deletion might be insufficient to fully correct the vascular defects because of an additional effect of LT-a on TNFR1. We therefore generated Tnfr1 À/À Hoip À/À animals and, in accordance with our hypothesis, Tnfr1
Hoip À/À embryos underwent early embryogenesis with normal vascularization and complete prevention of cell death in the yolk sac ( Figures 5B i and ii; Figure S5B ). Importantly, Tnfr1 À/À Hoip À/À embryos survived past E15.5 ( Figures   5B iii and vi) . Yet, at E17.5, the incidence of living embryos was not 100% ( Figure S5A ). Studying yolk sac vascularization at various developmental stages up to the time of death revealed that yolk sacs of Tnfr1
Hoip À/À embryos appeared normally vascularized throughout development, including at E13.5 and E15.5 and in embryos still alive at E17.5 ( Figure 5C ; Figures  S5C and S5D Figure 5C ; Figure S5C ). Taken together, these results show that TNFR1 deletion maintains integrity of the yolk sac vascular network of Hoip À/À embryos by preventing nonphysiological endothelial cell death induced by TNF and LT-a. While this result shows that in Hoip À/À embryos TNFR1-dependent aberrant cell death is responsible for disruption of yolk sac vascular architecture, other cytokines could be responsible for the remaining cell death observed in Tnfr1 À/À Hoip À/À embryos.
We therefore tested in vitro whether HOIP-deficient cells were more sensitive to cytokines other than TNF and LT-a and found that this was the case for CD95L, but not for interleukin-1b (IL1b) and IL-33 ( Figure S5E ). However, cell death induced by CD95L in the absence of HOIP, as compared to control cells, was not as pronounced as with TNF or LT-a (compare Figures  S5E and 5A ). Thus, although the remaining cell death observed at late gestation in yolk sacs of Tnfr1 À/À Hoip À/À embryos appears to bear no obvious functional consequences on vascularization ( Figure 5C ), CD95L could be responsible for this cell death. Despite re-enabling proper yolk sac vascularization, TNFR1 ablation in Hoip À/À animals could only further delay death during embryogenesis until E17.5 and not until birth or thereafter. This was surprising given that cIAP1/2-deficient mice are rescued by TNFR1 coablation to birth (Moulin et al., 2012) . It therefore appears that LUBAC plays a role in a cIAP1/2-independent pathway that becomes vitally important at around E16.5/17.5 as revealed by the Tnfr1
To understand the cause of their death, we analyzed them histologically. This revealed severe heart defects, with the atria and large blood vessels of the heart highly dilated and full of blood ( Figure 5F ). Blood vessels in other organs were also dilated suggesting cardiovascular failure ( Figure 5F ). Interestingly, this phenotype is not caused by excessive cell death in the heart ( Figure 5G ), indicating that ablation of TNFR1 rescues cell death both in the yolk sac and in the heart. Importantly, this phenotype was observed in mutants that were alive (i.e., showing heartbeat), implying the heart defects as a cause, not consequence, of death (Copp, 1995) . Intriguingly, a proportion of double-mutant embryos also showed neural tube closure defects of the anterior brain at E10.5 resulting in exencephaly at late gestation ( Figure S5F ). Taken together, we show that TNFR1-mediated cell death is causative for disruption of vascularization in HOIP-deficient embryos. However, we also discover that when both HOIP and TNFR1 are absent, morphological defects occur that appear to be independent of cell death but caused by HOIP deficiency.
HOIP-Deficient Cells Fail to Properly Activate NF-kB/ MAPKs and Aberrantly Form the Cell-Death-Inducing Complex-II Having identified aberrant TNFR1-mediated signaling as causative for lethality at midgestation to late gestation due to HOIP absence, we next assessed the molecular impact of HOIP deficiency on TNFR1 signaling. We first tested whether Hoip À/À cells still generated linear linkages upon TNF stimulation. To do so, we performed native TNF-RSC analysis as previously described (Gerlach et al., 2011; Haas et al., 2009) Figure 6B ). In addition to decreased gene-activatory signaling by the TNF-RSC, and consistent with the increased sensitivity to TNF/LT-a-induced cell death (Figure 5A) , we observed increased caspase-3 and caspase-8 cleavage ( Figure 6B ). As activation of these caspases is known to result from complex-II, we examined whether formation of this complex was aberrantly increased in cells devoid of HOIP in response to TNF. Strikingly, whereas its formation was undetectable in HOIP-proficient cells, complex-II was readily detectable in HOIP-deficient cells with robust recruitment of cleaved caspase-8, RIP1, and RIP3 to FADD ( Figure 6C ). Thus, absence of HOIP enables the premature and aberrant formation of the cell-death-inducing complex-II of TNFR1 signaling. Since this complex can mediate apoptotic and necroptotic death Murphy and Silke, 2014) we next determined the type(s) of cell death induced in HOIP-deficient MEFs. Treatment with the caspase inhibitor Q-Val-Asp(non-O-methylated)-OPh (QVD) or Necrostatin-1, an inhibitor of RIP1's kinase activity, partially blocked TNF-induced death in HOIP-deficient MEFs, which was further reduced by the combination thereof ( Figure 6D ). Taken together, these results show that deletion of HOIP on the one hand attenuates but does not prevent TNFR1-mediated gene activation and on the other hand markedly increases formation of complex-II, consequently enabling the induction of aberrant cell death upon stimulation by either of its ligands, TNF or LT-a.
HOIP's Catalytic Activity Is Required for Protection from TNF-Induced Cell Death
We finally aimed to determine whether HOIP's catalytic activity is required for protecting cells from TNF-induced death or whether the presence of HOIP, and thus of LUBAC, as a mere scaffold in the TNF-RSC rather than an enzymatically active component is responsible for this effect. To do so, we reconstituted Tnf À/À Hoip À/À MEFs with wild-type (WT) or catalytically inactive (C885S) HOIP. While reconstitution with both forms of HOIP restored expression of HOIL-1 and SHARPIN ( Figure 7A ), reconstitution with HOIP (C885S) failed to rescue TNF-induced activation of NF-kB and MAPK to normal levels ( Figure 7B ) and, importantly, also failed to prevent TNF-induced cell death, contrary to reconstitution with WT HOIP ( Figure 7C ). These results show that HOIP's catalytic activity is required for proper signaling output of the TNF-RSC.
DISCUSSION
Here, we show that constitutive deficiency in the enzymatically active component of LUBAC, HOIP, results in embryonic lethality at midgestation due to disruption of vascularization in the yolk sac and consequent cardiovascular failure. Specific deletion of Hoip from endothelial and immune precursor cells with Tie2-promoter-driven Cre resulted in the same phenotype as constitutive deletion of Hoip. Both constitutive and endothelial/immune-specific deletion of Hoip resulted in a substantial increase in death of endothelial cells in the yolk sac at midgestation, which is causative for disrupted vascularization and, consequently, death. Given that early hematopoiesis takes place in the yolk sac (Inlay et al., 2014) , it is difficult to ascertain whether the absence of HOIP from immune cells exerts a direct effect on them or whether the percentage reduction is due to the yolk sac itself degenerating as a consequence of endothelial cell death. However, although an effect of HOIP deficiency on immune cells cannot be formally excluded, given the substantial death of endothelial cells we observe in the yolk sacs of both HOIP-deficient and Hoip fl/fl Tie2-Cre+ embryos, which, importantly, occurs prior to reduction in viability of immune cells, we propose death of endothelial, and not immune, cells as the primary cause of embryonic lethality in Hoip À/À and Hoip fl/fl Tie2-Cre+ embryos. The fact that endothelial rather than other cells die in the embryo may be due to differential exposure to TNF and LT-a, which are known to play important roles in secondary lymphoid organ development. Alternatively, endothelial cells may be particularly dependent on HOIP for survival.
Genetic deletion of either TNF or TNFR1 in HOIP-deficient mice prevented cell death in yolk sacs, restored normal vascularization, and, crucially, rescued these embryos from death at E10.5. This implies that endothelial cell death causes disruption of the vascular network and argues against the possibility that HOIP deficiency leads to a defect in developmental pathways, such as angiogenesis. If this were the case, genetic coablation of TNF or TNFR1 would not suppress lethality at midgestation Although LT-a was the first TNF superfamily member to be cloned (Gray et al., 1984 ) and, like TNF, signals via TNFR1 (Etemadi et al., 2013 , TNF is the predominant ligand that drives TNFR1 signaling in vivo, as loss of TNF and TNFR1 phenocopy each other for most functions analyzed so far (Marino et al., 1997; Pasparakis et al., 1996; Rothe et al., 1993) . By contrast, deletion of LT-a most closely phenocopies loss of LT-b and LT-bR, since LT-a is required to form heterotrimeric LTa 1 LTb 2 (Browning et al., 1993; Crowe et al., 1994) . It is therefore noteworthy that in the pathological scenario of Hoip depletion, loss of TNF does not phenocopy loss of TNFR1, indicating a physiological role for the LTa 3 /TNFR1 signaling.
Histological analysis of Tnfr1
Hoip À/À embryos at E15.5 revealed severe morphological defects in the heart, which appear to be independent of cell death. In addition, a proportion of these embryos also exhibited exencephaly. Interestingly, abnormalities in neural crest induction or delamination have previously been shown to account for this particular combination of phenotypes (Barbera et al., 2002) , and these abnormalities could therefore also be causative for them in Tnfr1
Hoip À/À embryos. It is currently unclear, however, which cell-death-independent pathway is perturbed by absence of HOIP to result in these defects. A mutation in OTULIN, a deubiquitinase that specifically dismantles linear ubiquitin chains, causes embryonic lethality between E12.5 and 14.5. The authors showed that these embryos suffered from deficits in the cranial vasculature and suggested a role for OTULIN in canonical Wnt signaling during angiogenesis (Rivkin et al., 2013) . Although we determined the vascular defects in Hoip À/À embryos to be due to aberrant endothelial cell death rather than defective angiogenesis, Tnfr1 À/À Hoip À/À embryos had dramatic defects in the heart, most likely caused by aberrant neural crest induction. It is tempting to speculate that proper Wnt signaling, known to be required for various developmental processes during embryogenesis (Copp, 1995; van Amerongen and Berns, 2006) , could be perturbed in HOIP's absence and thereby responsible for the phenotype of Tnfr1
Reconstitution experiments performed in this study show that not only the physical presence of HOIP and LUBAC but also its catalytic activity in the TNF-RSC is required to prevent TNF-induced cell death. This result is in accordance with the recent mentioning of HOIP's catalytic activity as essential for embryogenesis (Emmerich et al., 2013) . Together, this shows that LUBAC and its linear-ubiquitin-forming activity are required to inhibit TNF-induced death for proper embryogenesis.
LUBAC forms part of the TNF-RSC and contributes to full NFkB activation. However, the findings we report here, in conjunction with the reported phenotypes of mice devoid of individual components of the TNF-triggered gene-activatory and cell death pathways, respectively, allow us to deduce that it is indeed the lack of proper control of cell death, importantly independently of the gene-activatory role of LUBAC, which is responsible for lethality of HOIP deficiency. The rationale for this conclusion is laid out in the next paragraph.
Indeed, we observed attenuated gene-activatory signaling in TNF-and LT-a-stimulated Tnf
Hoip
À/À MEFs, confirming a role for LUBAC in maintaining optimal NF-kB activation by the TNF-RSC. Yet, while NF-kB activation was only reduced, there was a robust formation of complex-II in HOIP-deficient cells upon TNF stimulation, which did not occur in HOIP-proficient cells. It therefore appears that aberrant complex-II formation is responsible for nonphysiological TNFR1-mediated death of endothelial cells in the yolk sac and, consequently, embryonic lethality of HOIP deficiency at midgestation. However, this alone would be insufficient to conclude that attenuated NFkB-mediated gene activation would not play a role in rendering cells more TNF sensitive in the absence of HOIP. Yet, if attenuated NF-kB activation were responsible, then mice with a complete lack in NF-kB activation should die at least as early as HOIP-deficient mice. This is, however, not the case. Instead, IKKa-deficient mice die perinatally (Takeda et al., 1999) , and IKKb and NEMO/IKKg deficiency results in embryonic lethality at late gestation (E12.5/14.5), yet from liver injury (Rudolph et al., 2000; Schmidt-Supprian et al., 2000; Tanaka et al., 1999) , hence a phenotype very different from the one we observed in Hoip À/À embryos. On the contrary, deficiency in components of the cell death complex, such as caspase-8, FADD, and FLIP, results in embryonic lethality at midgestation, precisely at E10.5 (Varfolomeev et al., 1998; Yeh et al., 1998 Yeh et al., , 2000 Zhang et al., 1998) , which, intriguingly, is also when caspase-8 was specifically deleted in endothelial cells (Kang et al., 2004) . Importantly, these deaths at midgestation were recently revealed to be due to aberrant necroptotic and/or apoptotic cell death, depending on which component was deleted (Dillon et al., 2012; Kaiser et al., 2011; Oberst et al., 2011; Zhang et al., 2011) . Together, our findings indicate that LUBAC-dependent cell death regulation is crucial for proper vascularization during midstages of embryogenesis and that the phenotype of HOIP-deficient embryos mimics the ones observed in the absence of cell-death-associated components. It will be interesting to assess the effect of interference with apoptosis and/or necroptosis by their concomitant genetic coinactivation (Dillon et al., 2012; Kaiser et al., 2011) . However, this analysis cannot realistically be achieved by conventional breeding strategies, since the genes encoding HOIP and RIP3 are located within 200 kbp of each other on chromosome 14 in mice.
In summary, we propose that due to lack of linear ubiquitination, the balance between TNF-induced gene activation and cell death is disturbed in HOIP-deficient embryos in favor of cell death and that the nonphysiological cell death resulting from this disbalance is responsible for the lethality caused by HOIP deficiency at midgestation.
EXPERIMENTAL PROCEDURES Mice
The HOIP-deficient mouse strain used for this study was created from embryonic stem cell clone EPD0161_5_A05 obtained from KOMP Repository (http:// www.komp.org) and generated by the Wellcome Trust Sanger Institute. Methods used on the targeted alleles have been previously described (Skarnes et al., 2011) . The targeting cassette was composed of a lacZ reporter gene plus a neomycin cassette flanked by Frt sites and exons 6 (ENSMUSE00000316844) to 11 (ENSMUSE00000316820) of the hoip gene flanked by loxP sites. The mice were generated via C57BL/6N ES cell microinjection into BALB/c blastocysts to generate chimeric mice, which were bred for germline transmission through the ES Cell to Mouse service of the Australian Phenomics Network. The chimeric progeny were bred to generate HOIP-floxed animals. The neomycin cassette was removed by crossing these mice with mice expressing the frt-deleter FlpE recombinase (C57BL/6J) (Farley et al., 2000) to remove the reporter gene. Subsequently, the progeny was crossed with transgenic mice expressing the loxP-deleter Cre recombinase purchased from JAX (6054, B6.C-Tg[CMV-Cre]1 Cgn/J) to generate fullknockout animals. Alternatively, transgenic mice expressing the Cre recombinase under the control of the Tie2 promoter (Tie2-Cre) (B6.Cg-Tg[Tek-cre] 1Ywa/J) (Gustafsson et al., 2001) were crossed with HOIP-floxed animals to delete HOIP specifically in endothelial cells. Tnf À/À mice were a gift from William Kaiser (B6;129S6), and Tnfr1 À/À mice were purchased from JAX (2818, B6.129-Tnfrsf1atm1Mak/J). All mice were crossed for at least five generations before the embryological studies. All mice were typed by PCR analysis. Colonies were fed ad libitum and kept under an appropriate UK project license.
Timed Matings, Histological Analysis, and In Situ Hybridization A single male was paired with one or two females, which were plug checked daily. The embryonic days were counted starting E0.5 on the day the vaginal plug was detected. The embryos were taken from the mothers at different developmental stages, fixed in 4% paraformaldehyde for 24 hr, refrigerated, and stored in methanol for further analysis. For histological purposes, embryos were paraffin embedded, and serial sections of 4 mm were performed. Sections were stained with hematoxylin and eosin (H&E). Eight sagittal serial sections of two different planes of the embryo were analyzed by a pathologist. In situ hybridization of whole-mount embryos was performed by standard procedures (Behringer, 2003) . The probe was generated by cloning a 1.3 kb region of Hoip cDNA in pcDNA3 vector. Sense and antisense probes were generated by in vitro transcription using digoxigenin-labeled dinucleotide triphosphates and SP6 and T7 promoters, respectively.
Statistical Analysis
Statistical significance was determined using unpaired Student's t test. A p value < 0.05 was considered significant and indicated with *p < 0.05, **p < 0.01, and ***p < 0.001. Alternatively, whenever stated, ANOVA for multiple comparisons was used. 
SUPPLEMENTAL INFORMATION
